Clinical Trial Update: Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for tirbanibulin 1% ointment in chronically sun-damaged facial skin with actinic keratosis (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• tirbanibulin 1% ointment (tirbanibulin)

Snippet

Sponsor: Medical University of Graz | Conditions: Actinic Keratosis | Phase 4 | Status: COMPLETED